TERMIUM® is the Government of Canada’s terminology and linguistic data bank. C12N15/ Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming. La présente invention concerne des compositions de microparticules, les microparticules étant constituées d’acides nucléiques et de cations non polymères et.

Author: Mazujind Maunris
Country: Ecuador
Language: English (Spanish)
Genre: Education
Published (Last): 18 April 2008
Pages: 409
PDF File Size: 8.6 Mb
ePub File Size: 20.92 Mb
ISBN: 273-2-77146-747-8
Downloads: 42530
Price: Free* [*Free Regsitration Required]
Uploader: Yozil

Retrograde transport of sirna and therapeutic uses to treat neurologic disorders. Procede ameliore de detection et d’identification de micro-organismes causes d’infections. Immobilizing and processing specimens on matrix materials for the identification of nucleic acid sequences. Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof. Intranasal administration of modulators of hypothalamic ATP-sensitive potassium channels.

Variable-speed wind power system with improved energy capture via multilevel conversion. Efficient, high-throughput production of human proteins in bacteria. Solution hybridization of nucleic acids with antisense probes having modified backbones. In situ forming implants—an attractive formulation principle for parenteral depot formulations. EP EPB1 fr Polymeres non charges a base de morpholine ayant des liaisons chirales phosphoreuses entre les sous-unites. Recent advances in the stereocontrolled synthesis of antisense phosphorothioates.

A1 Designated state s: EP Kind code of ref document: Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents. Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine.


AU Date of ref document: Layer-by-layer-assembled multilayer films for transcutaneous drug and vaccine delivery. Antisense oligonucleotides for inducing exon skipping and methods of use thereof.

Polynucléotide — Wikipédia

Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery. Kind code of ref document: CA CAA1 fr Oligonucleotide duplexes comprising dna-like and rna-like nucleotides and uses thereof.

Secuencia oligoribonucleotidica homologa a nucleiuqe region del cdna que codifica para el receptor cd40 humano y oligoribonucleotidos duplex, vectores, composiciones farmaceuticas y usos correspondientes.

A1 Designated state s: Mikrokapseln acidee gesteuerter freigabe sowie deren verwendung zur stimulierung des nervenfaserwachstums. Apparatus and method for simplifying the processes in creating a sealed space on slides to conduct molecular biological reactions therein.

Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists.

Microparticules biodegradables pour administration soutenue de medicaments therapeutiques. Method for isolating biomolecules from a biological sample with linear polymers. Date of ref document: Country of ref document: Multifunctional aide co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.

Acide ribonucleique double brin presentant une efficacite accrue dans un organisme. Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression. Extended dicer substrate agents and methods for the specific inhibition of gene expression.


EP2700414A1 – Acide nucléique auto-gélatinisable – Google Patents

Vaccines against diseases caused by bucleique organisms using antigens encapsulated within biodegradable-biocompatible microspheres. Antisense oligomers and methods for inducing immune tolerance and immunosuppression. Kind code of ref document: Can non-viral technologies knockdown the barriers to siRNA delivery and acie the next generation of cancer therapeutics? Kind code of ref document: RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid.

Fully embeddable chitosan microneedles as a jucleique release depot for intradermal vaccination. Composition renfermant de fines particules supportant un principe biologiquement actif ou dont ledit principe actif est maintenu par de telles particules, et procede de preparation.

A1 Designated state s: In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA—DNA carrying microparticles to dendritic cells. Test de malignite test de depistage du cancer par la reaction en chaine de la polymerase. Country of ref document: CN CNB zh US USB2 en Request for preliminary examination filed prior to expiration of 19th month from priority date pct application filed from